Skip to main content

Morphology of Pancreatic Islets: A Time Course of Pre-diabetes in Zucker Fatty Rats

  • Protocol
  • First Online:
Type 2 Diabetes

Part of the book series: Methods in Molecular Biology ((MIMB,volume 560))

Summary

The Zucker fatty rat (fa/fa; ZR) is considered as a model for pre-diabetes, as characterised by a genetic defect in the leptin receptor, which results in hyperphagia, insulin resistance, hyperinsulinaemia, hyperlipoproteinaemia, and obesity. These animals become glucose intolerant but do not develop type 2 diabetes. As a consequence of increased adiposity and insulin resistance, the endocrine pancreas of ZR undergoes adaptive and compensatory changes. Measurements of the time course of the pathological changes by the histological analysis of the pancreatic islet in combination with metabolic parameters are an effective way to reveal disease progression. A loss in glucose tolerance occurs in ZR by 10 weeks of age and progressively worsens by 19 weeks of age. This process is accompanied by impaired islet histology, changes of β-cell mass, and impaired islet function. The early expression of insulin resistance and glucose intolerance in ZR results in morphological and functional changes of pancreatic islets despite their capability to maintain normoglycaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weir G. C., Laybutt D. R., Kaneto H., Bonner-Weir S., and Sharma A. (2001). Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50 Suppl 1, S154–S159

    Article  PubMed  CAS  Google Scholar 

  2. Beck-Nielsen H. and Groop L. (1994). Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J. Clin. Invest.94, 1714–1721

    Article  PubMed  Google Scholar 

  3. Ferrannini E. (1998). Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev 19, 477–490

    Article  PubMed  CAS  Google Scholar 

  4. Ritzel R. A., Butler A. E., Rizza R. A., Veldhuis J. D., and Butler P. C. (2006). Relationship between β-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29, 717–718

    Article  PubMed  Google Scholar 

  5. Clark A., Jones L., de Koning E., Hansen B. C., and Matthews D. R. (2001). Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function? Diabetes 50, S169–S171

    Article  PubMed  CAS  Google Scholar 

  6. Chan C. B., Wright G. M., Wadowska D. W., MacPhail R. M., Ireland W. P., and Sulston K. W. (1998). Ultrastructural and secretory heterogeneity of fa/fa (Zucker) rat islets. Mol. Cell Endocrinol. 136, 119–129

    Article  PubMed  CAS  Google Scholar 

  7. Finegood D. T., McArthur M. D., Kojwang D., Thomas M. J., Topp B. G., Leonard T. et al (2001). Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50, 1021–1029

    Article  PubMed  CAS  Google Scholar 

  8. Tikellis C., Wookey P. J., Candido R., Andrikopoulos S., Thomas M. C., and Cooper M. E. (2004). Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 53, 989–997

    Article  PubMed  Google Scholar 

  9. Schröder D., Berg S., Altmann S., Lucke S., Augstein P., and Salzsieder E. (2006). Charakterisierung von Zucker fatty Ratten (fa/fa) - Beziehung von Stoffwechselparametern, Glukosetoleranz und Eigenschaften isolierter Langerhansscher Inseln. Diabetologie und Stoffwechsel 1, 64–A-132

    Article  Google Scholar 

  10. Berthiaume N., Mika A. K., and Zinker B. A. (2003). Development of insulin resistance and endothelin-1 levels in the Zucker fatty rat. Metab. Clin. Exp. 52, 845–849

    Article  PubMed  CAS  Google Scholar 

  11. Apweiler R. and Freud P. (1993). Development of glucose intolerance in obese (fa/fa) Zucker rats. Horm. Metab. Res. 25, 521–524

    Article  PubMed  CAS  Google Scholar 

  12. Wargent E., Stocker C., Augstein P., Heinke P., Meyer A., Hoffmann T. et al (2005). Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Diabetes Obes. Metab. 7, 170–181

    Article  PubMed  CAS  Google Scholar 

  13. Buckingham R. E., al Barazanji K. A., Toseland C. D., Slaughter M., Connor S. C., West A. et al (1998). Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47, 1326–1334

    Article  PubMed  CAS  Google Scholar 

  14. Augstein P., Schlosser M., Ziegler B., Hahmann J., Mauch L., and Ziegler M. (1996). Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes. Acta Histochem. 98, 229–241

    PubMed  CAS  Google Scholar 

  15. Augstein P., Elefanty A. G., Allison J., and Harrison L. C. (1998). Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41, 1381–1388

    Article  PubMed  CAS  Google Scholar 

  16. Romeis. Mikroskopische Technik. (17th ed) (1989). München; Wien; Baltimore: Urban ‘ Schwarzenberg

    Google Scholar 

  17. Hofman F. (2002). Immunohistochemistry. In: Current Protocols in Immunology. John Wiley & Sons, Inc., New York, 21.4.1–21.4.23

    Google Scholar 

  18. Augstein P., Braun B., Ziegler B., Woltanski K. P., and Ziegler M. (1992). Characterization of two porcine proinsulin reactive monoclonal antibodies by immunostaining of beta-cells in pancreatic sections of different species. Acta Histochem. 93, 433–440

    PubMed  CAS  Google Scholar 

  19. Witt S., Dietz H., Ziegler B., Keilacker H., and Ziegler M. (1988). Production and use of monoclonal glucagon and insulin antibodies - reduction of pancreatic insulin in rats by treatment with complete Freund’s adjuvant. Acta Histochem. Suppl 35, 217–223

    CAS  Google Scholar 

  20. Hahn H. J., Gerdes J., Lucke S., Liepe L., Kauert C., Volk H. D. et al (1988). Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy. Eur. J. Immunol. 18, 2037–2042

    Article  PubMed  CAS  Google Scholar 

  21. Lucke S., Ziegler B., Weidlich K., Barowski U., Besch W., and Hahn H. J. (1985). The effects of subdiabetogenic streptozotocin doses on rat beta cell volume and functions. Biomed. Biochim. Acta 44, 167–171

    PubMed  CAS  Google Scholar 

  22. Weibel E. R. (1969). Stereological principles for morphometry in electron microscopic cytology. Int. Rev. Cytol. 26, 235–302

    Article  PubMed  CAS  Google Scholar 

  23. Lucke S. (1987) Die Bedeutung der reduzierten β-Zellmasse für die Regeneration der insulinproduzierenden Zellen im Rattenpankreas. Dissertation 1-81. Ernst-Moritz-Arndt-Universität-Greifswald

    Google Scholar 

  24. Kohnert K. D., Ziegler B., Falt K., Odselius R., Ziegler M., and Falkmer S. (1987). Biochemical, immunohistochemical and ultrastructural studies of the alteration of pancreatic beta cells resulting from the combined effects of complete Freund’s adjuvant and non-diabetogenic doses of streptozotocin. Exp. Clin. Endocrinol. 89, 259–268

    Article  PubMed  CAS  Google Scholar 

  25. Lucke S., Radloff E., Laube R., and Hahn H. J. (1991). Morphology of the endocrine pancreas in cyclosporine-treated glucose-intolerant Wistar rats. Anat. Anz. 172, 351–358

    PubMed  CAS  Google Scholar 

  26. Kohnert K. D., Falt K., Witt S., Ziegler B., and Ziegler M. (1988). Identification of monoclonal antibodies to pancreatic islet cells by immunoperoxidase staining. Acta Histochem. 83, 159–165

    PubMed  CAS  Google Scholar 

  27. Augstein P., Braun B., Ziegler B., Woltanski K. P., and Ziegler M. (1992). Characterization of two porcine proinsulin reactive monoclonal antibodies by immunostaining of beta-cells in pancreatic sections of different species. Acta Histochem. 93, 433–440

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors are grateful to Silke Lucke (PhD) and Klaus-Dieter Kohnert (PhD, MD) for their advice and for sharing their expertise. Our special thanks go to Peter Heinke (MSc.) for his excellent and competent support for mathematical and statistical evaluations. We acknowledge the contributions of Dieter Schröder (PhD) and Sabine Berg (MSc.). We thank Dr. Klaus-Dieter Kohnert for a critical review of the manuscript, Mrs. Cordula Rudolph and Mrs. Marlies Behm for excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Petra Augstein .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Augstein, P., Salzsieder, E. (2009). Morphology of Pancreatic Islets: A Time Course of Pre-diabetes in Zucker Fatty Rats. In: Stocker, C. (eds) Type 2 Diabetes. Methods in Molecular Biology, vol 560. Humana Press. https://doi.org/10.1007/978-1-59745-448-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-448-3_12

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-15-2

  • Online ISBN: 978-1-59745-448-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics